Updating FDA regulations for cosmetics manufacturing this year could be linked to legislation on establishing a user fee program to pay for improving its OTC drug monograph program, according to members of the House committee with oversight of the agency.
At a Sept. 11 hearing, members of the Energy and Commerce Committee's Health Subcommittee suggested that their support for potential OTC monograph reform legislation depends on including provisions that would...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?